News

Biogen has officially announced its decision to discontinue all development and sales of aducanumab (Aduhelm) for Alzheimer disease.

Here are some updates from the world of psychiatry throughout the month of January.

When exploring urgent treatment options for your patients, be sure to look at the bigger picture before you push the panic button.

The FDA granted clearance for a transcranial magnetic stimulation technology indicated for major depressive disorder and obsessive-compulsive disorder.

Did you know January is Poverty Awareness Month?

To divide or not to divide? Researchers compared clinical features, side effects, and blood levels between once daily versus divided clozapine dosing regimens.

The unity students have shown at Ball State is a model worth replicating.

The experts weighed in on a wide variety of psychiatric issues for the January 2024 issue of Psychiatric Times.

From noninvasive brain stimulation for substance use disorders to updates from APSARD 2024, here are highlights from the week in Psychiatric Times.

A "global human energy crisis" is coming. How can emotional intelligence help us navigate it?

What is new in research on clinician wellness?

The latest report on physician burnout is here...

The candidate also aims to address neurodevelopmental and neurodegenerative disorders such as Parkinson disease and Rett syndrome.

Check out these APSARD 2024 updates from Greg Mattingly, MD, president of the American Professional Society for ADHD and Related Disorders.

Election year has rolled around again… what role do psychiatrists and mental health clinicians play in these tense times?

US suicide rates reached an all-time high in 2022. Here’s how effective implementation of 988 can help address the problem.

Brain injury associated fatigue and altered cognition has been associated with a subset of individuals with mild traumatic brain injuries who develop posttraumatic hypopituitarism, including altered gut microbiome and amino acid utilization.

What if psychiatrists provided their insights to the community via residency?

In this CME article, review the current treatment modalities for noninvasive brain stimulation in the treatment of substance use disorders, and to explore the potential for further expansion of indications.

What does it mean to be humanitarian?

From clinician wellness to THC use in adolescents, here are highlights from the week in Psychiatric Times.

This APSARD 2024 conference poster finds that individuals with ADHD have distinct motivations and patterns of substance use.

The results were shared in a poster presentation at the 2024 APSARD Annual Meeting.

What is new in research on COVID-19 and mental health?

Working in the health care profession is a privilege, yet it also carries some personal risks. Only when clinicians who have sought and successfully received help for depression, suicidality, and other mental illness come forward to share their experience will more of clinicians in need of psychiatric treatment feel comfortable seeking and receiving that care.

When we say “Happy New Year,” how can we ensure that wish leads to genuine happiness for others?

Take a look back at our recent coverage relating to our January content theme.

Here is a glimpse into the understated yet basic importance of taking a lunch break as a way of recharging during the workday.

The diversity of the arts leads the way for greater social change…

Regular THC use in adolescence is not a benign activity—it can have life-changing consequences. Here’s what you need to know.